These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8470265)

  • 1. Transforming growth factor-beta and organ transplantation.
    Waltenberger J; Miyazono K; Funa K; Wanders A; Fellström B; Heldin CH
    Transplant Proc; 1993 Apr; 25(2):2038-40. PubMed ID: 8470265
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of cardiac allograft survival with transforming growth factor-beta 1 in rats.
    Raju GP; Belland SE; Eisen HJ
    Transplantation; 1994 Aug; 58(3):392-6. PubMed ID: 8053069
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression with the vitamin D analogue MC 1288 in experimental transplantation.
    Johnsson C; Binderup L; Tufveson G
    Transplant Proc; 1996 Apr; 28(2):888-91. PubMed ID: 8623448
    [No Abstract]   [Full Text] [Related]  

  • 4. Transforming growth factor-beta signaling is enhanced following mitomycin-C treatment of islet xenograft.
    Ise K; Sato Y; Matsuyama S; Gunji T; Ishii S; Yamashita M; Kanazawa Y; Gotoh M
    Transplant Proc; 2004 May; 36(4):1183-5. PubMed ID: 15194410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of concordant islet xenografts with leflunomide.
    Lakey JR; Yatscoff RW; Koshal A; Rajotte RV
    Transplant Proc; 1996 Apr; 28(2):816. PubMed ID: 8623414
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of canine pancreas allografts with cyclosporin A.
    McMaster P; Procyshyn A; Calne RY; Valdes R; Rolles K; Smith D
    Transplant Proc; 1980 Jun; 12(2):275-7. PubMed ID: 6771904
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New perspectives in organ transplantations].
    Bruzzone P
    Clin Ter; 2005; 156(6):299-310. PubMed ID: 16463567
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
    Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancreas transplantation--between experiment and clinical method].
    Klempnauer J; Lück R; Hiller WF; Bektas H; Meier P; Pichlmayr R
    Internist (Berl); 1996 Mar; 37(3):289-94. PubMed ID: 8919946
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in xenotransplantation.
    Hammer C
    Transplant Proc; 1996 Dec; 28(6):3017-20. PubMed ID: 8962171
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in immune-based therapies to improve solid organ graft survival.
    Rose SM; Turka L; Kerr L; Rotrosen D
    Adv Intern Med; 2001; 47():293-331. PubMed ID: 11795079
    [No Abstract]   [Full Text] [Related]  

  • 15. Islet cell transplantation.
    Vaithilingam V; Sundaram G; Tuch BE
    Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance.
    Cheng J; Xia SS; Xie S; Tang LG; Shi XF
    Transplant Proc; 2005 Jun; 37(5):2360-4. PubMed ID: 15964416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interferon alpha/beta on cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
    Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
    [No Abstract]   [Full Text] [Related]  

  • 19. Xanthines: ideal immunosuppressants for combination with cyclosporine?
    Lin Y; Segers C; Mikhalsky D; Schönharting M; Waer M
    Transplant Proc; 1996 Dec; 28(6):3102. PubMed ID: 8962202
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats.
    Balamurugan AN; Nelson EJ; Ramakrishna B; Gunasekaran S
    Xenotransplantation; 2007 Jul; 14(4):316-22. PubMed ID: 17669173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.